|
⚲
|
| Keyboard |
| Atlas Venture Fund XII LP
✚
|
|
|---|---|
| CIK # | 0001812049 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001812049] | |
| 4 | [0001812049] | |
| D | [0001812049] | |
| SC 13D | [0001812049] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Atlas Venture Fund XII LP | Vigil Neuroscience Inc | [2022-01-21] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2025-08-05 | Disposed to issuer | 4,808,896 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2025-08-05 | Disposed to issuer | 1,027,978 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2022-07-15 | Other | 310,388 | $0.00 | |
|
Jade Biosciences Inc AVTE
Common Stock
|
2022-04-01 | Other | 465,582 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 2,850,789 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 2,831,520 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 535,000 | $14.00 | 7,490,000 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 1,027,978 | ||
|
Vigil Neuroscience Inc VIGL
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 7,852,374 | $0.00 | |
|
Jade Biosciences Inc AVTE
Series A Preferred Stock · derivative
|
2021-07-02 | Conversion | 7,976,754 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Conversion | 2,568,165 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Buy | 535,714 | $14.00 | 7,499,996 |